BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27357212)

  • 1. Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations.
    Khundakar AA; Hanson PS; Erskine D; Lax NZ; Roscamp J; Karyka E; Tsefou E; Singh P; Cockell SJ; Gribben A; Ramsay L; Blain PG; Mosimann UP; Lett DJ; Elstner M; Turnbull DM; Xiang CC; Brownstein MJ; O'Brien JT; Taylor JP; Attems J; Thomas AJ; McKeith IG; Morris CM
    Acta Neuropathol Commun; 2016 Jun; 4(1):66. PubMed ID: 27357212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual hallucinations in Alzheimer's disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas.
    Sinclair LI; Kumar A; Darreh-Shori T; Love S
    Alzheimers Res Ther; 2019 Sep; 11(1):80. PubMed ID: 31511061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlates of pathology in the claustrum in Parkinson's disease and dementia with Lewy bodies.
    Kalaitzakis ME; Pearce RK; Gentleman SM
    Neurosci Lett; 2009 Sep; 461(1):12-5. PubMed ID: 19523504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal Loss and Α-Synuclein Pathology in the Superior Colliculus and Its Relationship to Visual Hallucinations in Dementia with Lewy Bodies.
    Erskine D; Thomas AJ; Taylor JP; Savage MA; Attems J; McKeith IG; Morris CM; Khundakar AA
    Am J Geriatr Psychiatry; 2017 Jun; 25(6):595-604. PubMed ID: 28190674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB).
    Imamura T; Ishii K; Hirono N; Hashimoto M; Tanimukai S; Kazuai H; Hanihara T; Sasaki M; Mori E
    Neuroreport; 1999 Jun; 10(9):1903-7. PubMed ID: 10501530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathological investigation of hypocretin expression in brains of dementia with Lewy bodies.
    Kasanuki K; Iseki E; Kondo D; Fujishiro H; Minegishi M; Sato K; Katsuse O; Hino H; Kosaka K; Arai H
    Neurosci Lett; 2014 May; 569():68-73. PubMed ID: 24704327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load.
    Chong JR; Chai YL; Lee JH; Howlett D; Attems J; Ballard CG; Aarsland D; Francis PT; Chen CP; Lai MK
    J Alzheimers Dis; 2017; 56(1):157-166. PubMed ID: 27911312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
    Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
    Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific patterns of neuronal loss in the pulvinar nucleus in dementia with lewy bodies.
    Erskine D; Thomas AJ; Attems J; Taylor JP; McKeith IG; Morris CM; Khundakar AA
    Mov Disord; 2017 Mar; 32(3):414-422. PubMed ID: 28059471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
    Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
    Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies.
    Kasanuki K; Iseki E; Fujishiro H; Yamamoto R; Higashi S; Minegishi M; Togo T; Katsuse O; Uchikado H; Furukawa Y; Hino H; Kosaka K; Sato K; Arai H
    J Neurol Sci; 2012 Mar; 314(1-2):111-9. PubMed ID: 22041339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical associations of tau in Lewy body dementias: A systematic review and meta-analysis.
    Chin KS; Yassi N; Churilov L; Masters CL; Watson R
    Parkinsonism Relat Disord; 2020 Nov; 80():184-193. PubMed ID: 33260030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.
    Chai YL; Chong JR; Weng J; Howlett D; Halsey A; Lee JH; Attems J; Aarsland D; Francis PT; Chen CP; Lai MKP
    Brain Pathol; 2019 Jan; 29(1):63-74. PubMed ID: 30051532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.
    Vaikath NN; Erskine D; Morris CM; Majbour NK; Vekrellis K; Li JY; El-Agnaf OMA
    Neuropathol Appl Neurobiol; 2019 Oct; 45(6):597-608. PubMed ID: 30422353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the identification of dementia with Lewy bodies in the context of an Alzheimer's-type dementia.
    Thomas AJ; Mahin-Babaei F; Saidi M; Lett D; Taylor JP; Walker L; Attems J
    Alzheimers Res Ther; 2018 Mar; 10(1):27. PubMed ID: 29490691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
    Walker L; McAleese KE; Thomas AJ; Johnson M; Martin-Ruiz C; Parker C; Colloby SJ; Jellinger K; Attems J
    Acta Neuropathol; 2015 May; 129(5):729-48. PubMed ID: 25758940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study.
    Taylor JP; Firbank M; Barnett N; Pearce S; Livingstone A; Mosimann U; Eyre J; McKeith IG; O'Brien JT
    Br J Psychiatry; 2011 Dec; 199(6):492-500. PubMed ID: 22016436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
    Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
    Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies.
    Fixemer S; Ameli C; Hammer G; Salamanca L; Uriarte Huarte O; Schwartz C; Gérardy JJ; Mechawar N; Skupin A; Mittelbronn M; Bouvier DS
    Acta Neuropathol Commun; 2022 Mar; 10(1):36. PubMed ID: 35296366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuritic alterations and neural system dysfunction in Alzheimer's disease and dementia with Lewy bodies.
    Klucken J; McLean PJ; Gomez-Tortosa E; Ingelsson M; Hyman BT
    Neurochem Res; 2003 Nov; 28(11):1683-91. PubMed ID: 14584822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.